|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Statements for the Year Ended 31 December 2018 |
|
for |
|
IBA Molecular UK Limited |
|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Statements for the Year Ended 31 December 2018 |
|
for |
|
IBA Molecular UK Limited |
IBA Molecular UK Limited (Registered number: 04794962) |
|
|
|
|
|
|
Contents of the Financial Statements |
for the Year Ended 31 December 2018 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
Notes to the Financial Statements | 3 |
|
IBA Molecular UK Limited |
|
Company Information |
for the Year Ended 31 December 2018 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
AUDITORS: |
|
and Chartered Accountants |
Elm House, Tanshire Park |
Shackleford Road, Elstead |
Godalming |
Surrey |
GU8 6LB |
IBA Molecular UK Limited (Registered number: 04794962) |
|
Balance Sheet |
31 December 2018 |
|
31.12.18 | 31.12.17 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors: amounts falling due within one
year |
3 |
|
|
Debtors: amounts falling due after more than
one year |
3 |
|
|
Cash in hand |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 4 |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
PROVISIONS FOR LIABILITIES |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital |
|
|
Retained earnings |
( |
) |
( |
) |
|
|
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
|
The financial statements were approved by the Board of Directors on
by: |
|
|
|
|
|
|
|
IBA Molecular UK Limited (Registered number: 04794962) |
|
Notes to the Financial Statements |
for the Year Ended 31 December 2018 |
|
1. | STATUTORY INFORMATION |
|
IBA Molecular UK Limited is a
|
company's registered number and registered office address can be found on the Company Information page. |
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Related party exemption |
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The |
Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party |
transactions with wholly owned subsidiaries within the group. |
|
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to |
the extent that it relates to items recognised in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or |
substantively enacted by the balance sheet date. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the |
balance sheet date. |
|
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from |
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws |
that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of |
the timing difference. |
|
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they |
will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
|
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the |
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling |
at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
|
Decommissioning provision |
A decommissioning provision is recognised when a site is constructed to provide for the expected costs payable |
to decommission it in accordance with the lease agreements and local regulatory requirements. |
|
The provisions are calculated by management with reference to the work of external experts in the field and are |
discounted to reflect the time value of money where this is material. |
|
Going concern |
At the balance sheet date the company's current liabilities exceeded its assets due within one year. However, the |
Directors are confident of the continued support of the holding company and consequently the accounts have |
been prepared on a going concern basis. |
IBA Molecular UK Limited (Registered number: 04794962) |
|
Notes to the Financial Statements - continued |
for the Year Ended 31 December 2018 |
|
3. | DEBTORS |
31.12.18 | 31.12.17 |
£ | £ |
Amounts falling due within one year: |
Trade debtors |
|
|
Other debtors |
|
|
|
|
|
Amounts falling due after more than one year: |
Other debtors |
|
|
|
Aggregate amounts |
|
|
|
4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.12.18 | 31.12.17 |
£ | £ |
Trade creditors |
|
|
Taxation and social security |
|
|
Other creditors |
|
|
|
|
|
5. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
|
The Report of the Auditors was unqualified. |
|
|
for and on behalf of
|
|
6. | ULTIMATE CONTROLLING PARTY |
|
The company is a wholly owned subsidiary of Curium International SA, a company incorporated in Belgium. |
The ultimate holding company is Glo HoldCo SCA, a company incorporated in Luxembourg. |
|
The smallest group for which consolidated accounts are prepared is Curium MidCo S.à r.l., a company |
registered in Luxembourg, with registered office at 13, rue Aldringen, L-1118 Luxembourg, Grand Duchy of |
Luxembourg. |